跳至主要内容
临床试验/EUCTR2005-001726-80-SE
EUCTR2005-001726-80-SE进行中(未招募)不适用

Effects of new longacting insulin analogs on metabolic control, endogenous insulin production, GH/IGF-I axis and quality of life – comparison of NPH, glargine och detemir insulin from the debut of T1DM in adolescents - Basal analog study

Karolinska University Hospital, Stockholms Läns Landsting0 个研究点目标入组 120 人开始时间: 2005年6月17日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
发起方
入组人数
120

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • 1)Diagnosis of Diabetes Mellitus and novel to insulin therapy
  • 2)Age 7.0-16.99 years
  • 3)Informed consent
  • Are the trial subjects under 18? yes
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) no
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • 1) Moderate to severe ketoacidosis
  • (pH<7.2 and/or standardbicarbonate <10 mmol/l)
  • 2)Suspected non-type 1
  • 3)IA2, GAD65, IAA: all-antibody negative
  • 4)Celiac disease or other chronic disease
  • 5)Hypothyroidism, if not well controlled
  • 6)Syndromes
  • 7)Previous anorexia nervosa
  • 8)Neuro-psychiatric disease

研究者

发起方
Karolinska University Hospital, Stockholms Läns Landsting

相似试验